Results 31 to 40 of about 21,379 (299)

EXTRAOCULAR SEBACEOUS CARCINOMA ARISING FROM NEVUS SEBACEOUS [PDF]

Acta Medica Iranica, 2005
Sebaceous carcinoma is a relatively rare cutaneous tumor that is most commonly derived from the sebaceous glands located in periorbital area. The extraocular occurrence of this tumor is very rare.
D. Akbari, Z. Naraghi, N. Emadi H. Ghaninejad   +2 more
doaj   +2 more sources

KARSINOMA KELENJAR SEBASEA DI PALPEBRA SUPERIOR MATA KIRI: LAPORAN KASUS

JKS (Jurnal Kedokteran Syiah Kuala), 2021
Abstrac: Sebaceous gland carcinoma is a rare and fast-growing, potentially lethal skin malignant tumor originating from the adnexal epithelium of the sebaceous glands. This carcinoma is more common in the superior palpebral than the inferior palpebral in
Raudatul Janah
doaj   +1 more source

Sebaceous Carcinoma

Torres-Laboy P, Schmieder SJ.
europepmc   +2 more sources

Sebaceous carcinoma over cheek: A rare presentation

Medical Journal of Dr. D.Y. Patil University, 2014
Sebaceous carcinoma, an uncommon cutaneous tumor first described by Allaire in 1891. This arises mostly from sebaceous glands in the skin and thus may arise anywhere in the body where these glands exist.
Dakshayani S Nirhale, Amit Parasnis, Virendra S Athavale, Mohit Bhatia   +3 more
doaj   +1 more source

GLUT1 Expression in Cutaneous Sebaceous Lesions Determined by Immunohistochemical Staining Patterns

Dermatopathology, 2021
GLUT1 is a membrane associated carrier protein that functions in the physiologic transport of glucose across cell membranes. Multiple studies have shown an increased GLUT1 expression in various tumor types and a role in cancer prognosis.
Cynthia Reyes Barron, Bruce R. Smoller
doaj   +1 more source

Role of microsatellite instability, immunohistochemistry and Mismatch Repair germline aberrations in immunosuppressed transplant patients: a phenocopy dilemma in Muir-Torre Syndrome. [PDF]

, 2016
Sebaceous tumours and keratoacanthomas are uncommon neoplasms that constitute important clinical criteria for Muir-Torre Syndrome (MTS) diagnosis. In MTS patients, the increased risk of developing synchronous or metachronous visceral malignancies is ...
Manfredini, Marco, Pellacani, Giovanni, Ponti, Giovanni, Tomasi, Aldo   +3 more
core   +1 more source

FDG-PET-positive lower-extremity sebaceous-gland carcinoma in a patient with Muir-Torre syndrome

Radiology Case Reports, 2015
Sebaceous-gland carcinoma can occur alone or as one of the defining features of the Muir-Torre syndrome. Cases occurring below the head and neck are extremely rare.
Bina Kviatkovsky, MSc, Elliot Landau, MD, Muhammad Siddique, MBBS, Sami Hossri, MD, Anoosheh Ebaee, MD, Jean Paul Attalah, MD, Antonio Picon, MD, Arnold Brenner, DO   +7 more
doaj   +1 more source

Locally Advanced Spiroadenocarcinoma in the Regional Axilla of a Breast Cancer Patient: Hallmarks of Definitive Diagnosis and Management. [PDF]

, 2015
Eccrine spiroadenocarcinoma is an extremely rare malignant eccrine gland tumor which may masquerade as other more common malignancies such as poorly differentiated squamous carcinoma or metastatic breast cancer.
Canter, Robert J, Fung, Maxwell A, Gingrich, Alicia A, Konia, Thomas   +3 more
core   +2 more sources

Benign follicular tumors [PDF]

, 2015
Benign follicular tumors comprise a large and heterogeneous group of neoplasms that share a common histogenesis and display morphological features resembling one or several portions of the normal hair follicle, or recapitulate part of its embryological ...
Ackerman AB, Agoston AT, Al-Arashi MY, Alsina MM, Ana Rita Gameiro, António Poiares Baptista, Baptista AP, Barr RJ, Batman PA, Betti R, Blaya B, Brownstein MH, Brownstein MH, Cardoso JC, Carr RA, Chan EF, Cho S, Cribier B, Córdoba A, Eng C, Eng C, Findlay GH, Happle R, Harris A, Herrmann JL, Hoang MP, Hunt SJ, Inês Coutinho, José Carlos Cardoso, José Pedro Reis, Kazakov DV, Kimura T, Kossard S, Kutzner H, Lee DA, Leonardi CL, Leonor Ramos, McKenna DB, Mehregan AH, Mehregan AH, Misago N, Misago N, Misago N, Oscar Tellechea, Parren LJ, Pilarski R, Poiares Baptista A, Rahbari H, Reese E, Resnik KS, Rohwedder A, Rosso R, Sangueza OP, Sau P, Schnitzler L, Schulz T, Serra D, Shimanovich I, Shvartsbeyn M, Starink TM, Steffen C, Stierman S, Tellechea O, Tellechea O, Tellechea O, Tellechea O, Weyers W, Winer LH   +67 more
core   +3 more sources

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

Molecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano, Giuseppina Minopoli, Simona Romano, Laura Marrone, Katia Aquilano, Maria Lina Tornesello, Raffaella Faraonio   +6 more
wiley   +1 more source